Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6197 results
Lymphoma cells

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

by In collaboration with PA Media Group | News | 23 May 2022

23 May 2022

This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic. This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

by Phil Prime | Podcast | 23 May 2022

23 May 2022

This entry is part 3 of 9 in the series Cancer Research Matters - series 1
%postcontent%

Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes. Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes.

by Phil Prime | Interview | 16 May 2022

16 May 2022

The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK. The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK.

by Cancer Research UK | In depth | 13 May 2022

13 May 2022

A couple holding hands in a doctor's waiting room

New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month. New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.

by Jacob Smith | News | 9 May 2022

9 May 2022

Patrick McGuire, one of our Campaigns Ambassadors, with his partner Sue

To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government's upcoming 10-year Cancer Plan. To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government's upcoming 10-year Cancer Plan.

by Jacob Smith | Analysis | 6 May 2022

6 May 2022

Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons

by Phil Prime | Analysis | 3 May 2022

3 May 2022

A patient receiving chemotherapy

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

by Jacob Smith | News | 2 May 2022

2 May 2022

We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels

by Phil Prime | Interview | 29 April 2022

29 April 2022

We are jointly funding a follow-up study which will find the final evidence on the impact on oesophageal cancer mortality of screening using the Cytosponge. We are jointly funding a follow-up study which will find the final evidence on the impact on oesophageal cancer mortality of screening using the Cytosponge.

by Phil Prime | In depth | 28 April 2022

28 April 2022